Viva Biotech Holdings (FRA:VB0)

Viva Biotech Holdings Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	471	226	260	402	1,020	1,844
Market Cap Growth	100.94%	-13.23%	-35.25%	-60.56%	-44.70%	126.37%
Enterprise Value	503	295	490	697	1,183	1,683
Last Close Price	0.22	0.10	0.11	0.20	0.50	0.89
PE Ratio	22.98	10.21	-	-	25.63	-
PS Ratio	2.16	0.86	0.95	1.25	3.50	21.13
PB Ratio	1.01	0.45	0.55	0.82	1.88	3.92
P/TBV Ratio	2.83	1.33	1.84	3.05	6.01	10.23
P/FCF Ratio	18.48	9.32	10.43	21.69	-	-
P/OCF Ratio	11.27	4.57	5.32	7.68	94.67	341.11
EV/Sales Ratio	2.26	1.12	1.78	2.16	4.06	19.28
EV/EBITDA Ratio	9.33	5.16	9.81	11.78	23.11	81.76
EV/EBIT Ratio	18.22	9.71	19.92	19.32	36.09	119.41
EV/FCF Ratio	19.74	12.17	19.61	37.58	-	-
Debt / Equity Ratio	0.30	0.34	0.52	0.78	0.68	0.79
Debt / EBITDA Ratio	2.59	2.90	4.71	6.25	6.81	16.25
Debt / FCF Ratio	5.39	7.01	9.72	20.65	-	-
Asset Turnover	0.26	0.27	0.28	0.30	0.26	0.14
Inventory Turnover	4.24	4.88	4.84	5.61	7.33	4.53
Quick Ratio	1.22	1.26	1.03	0.44	1.44	3.75
Current Ratio	1.76	1.67	1.32	0.73	2.14	4.56
Return on Equity (ROE)	5.87%	5.92%	-2.74%	-13.41%	7.84%	-13.69%
Return on Assets (ROA)	2.03%	1.98%	1.57%	2.08%	1.83%	1.40%
Return on Capital (ROIC)	2.75%	2.69%	2.00%	2.56%	2.23%	1.65%
Return on Capital Employed (ROCE)	3.90%	3.90%	3.30%	5.10%	3.30%	1.50%
Earnings Yield	4.35%	9.80%	-5.69%	-17.82%	3.90%	-2.63%
FCF Yield	5.41%	10.73%	9.59%	4.61%	-6.61%	-3.73%
Dividend Yield	-	-	-	-	-	0.33%
Payout Ratio	-	-	-	-	5.66%	-
Buyback Yield / Dilution	-48.61%	-41.39%	-5.91%	2.81%	-25.41%	-5.83%
Total Shareholder Return	-48.61%	-41.39%	-5.91%	2.81%	-25.41%	-5.50%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.